張磊，主任醫(yī)師，博士研究生導(dǎo)師，長期從事血液病臨床及基礎(chǔ)工作，在專業(yè)領(lǐng)域做出了一系列原創(chuàng)性成果。在NEJM，BMJ，Nat Med等國內(nèi)外知名期刊發(fā)表SCI論文百余篇，獲得國家發(fā)明專利8項(xiàng)。曾獲2009年度國家科技進(jìn)步二等獎(jiǎng)、2023年度天津市科學(xué)技術(shù)進(jìn)步一等獎(jiǎng)等國家級及省部級獎(jiǎng)項(xiàng)9項(xiàng)。獲得國家科技創(chuàng)新領(lǐng)軍人才、天津市杰出人才等項(xiàng)目資助。獲國務(wù)院政府特殊津貼專家、國家衛(wèi)生健康突出貢獻(xiàn)中青年專家等稱號。

長期從事出凝血疾病以及基因治療方面的研究。牽頭開展亞洲首項(xiàng)血友病基因治療臨床試驗(yàn)，全球首次實(shí)現(xiàn)基因治療患者安全接受大手術(shù)，牽頭完成8項(xiàng)基因治療臨床研究，治愈百余名重癥血友病患者，并推動中國首個(gè)血友病基因治療產(chǎn)品注冊試驗(yàn)進(jìn)入III期臨床；利用新型CD38單抗實(shí)現(xiàn)血小板減少癥的持續(xù)穩(wěn)定治愈。相關(guān)成果入選年度“中國十大醫(yī)學(xué)科技新聞”和“血液學(xué)十大研究進(jìn)展”等。在NEJM，BMJ，Nat Med等國際頂尖期刊發(fā)表SCI論文百余篇。培養(yǎng)博士、碩士、博士后30余名。

久久综合九色欧美综合狠狠_伊人热热久久原色播放WWW_成A人片亚洲日本久久_久久不见久久见免费影院www日本_97久久精品人人做人人爽,又色又爽又黄的视频在线观看,狼群影院视频在线观看高清版,亚洲AV无码精品网站性色,国产乱码久久久久久红粉影视,精品国产乱码久久久久久一区二区,国产精品免费视频网站,国产A级毛片久久久久久精品,一级特黄高清aaaa大片,亚洲中文字幕欧美一区,久久精品国产99久久狂热,黑人巨大精品欧美_黑人巨大精品欧美黑寡妇_黑人巨大精品欧美一区二区_黑人巨大精品欧美一区二区免费_黑人巨大跨种族video_黑人巨大无码中文字幕无码_黑人巨茎大战俄罗斯美女_黑人巨茎大战俄罗斯美女,中文字幕av不卡|亚洲欧美国产另类|天天干在线播放|日韩黄视频|欧美七区|可以免费看毛片的网站|黄色片在线|国产精品96久久久久久

1. Xue F#, Ju M#, Zhu T#, Zhou Z#, Sun J, Yang L, Yan Z, Zhou H, Du X, Zheng C, Zheng J, Wu X, Du Z, Jiang W, Yang C, Xiao X, Liu W, Yang R, Zhang L*. Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials. Nature Medicine. 2025 Nov 20. Online ahead of print. (IF=50.319, PIII)

2. Chen Y#, Xu Y#, Dai J#, Sun T#, Li H#, Hua Z#, Zhou Z, Zhou H, Yan Z, Zhao X, Xue F, Liu W, Liu X, Fu R, Wang W, Chi Y, Dong H, Ju M, Dai X, Gu W, Pei X, Yang R, Zhang L*. Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial. British Medical Journal. 2025 Oct 21;391:e084314. ( IF=42.7)

3. Sun T#, Chen Y#, Zhang L*. Daratumumab in Relapsed or Refractory Pediatric Immune Thrombocytopenia. New England Journal of Medicine. 2025 May 29;392(20):2069-2071. (IF=96.2)

4. Chen Y#, Xu Y#, Li H#, Sun T#, Cao X#, Wang Y, Xue F, Liu W, Liu X, Dong H, Fu R, Dai X, Wang W, Ma Y, Song Z, Chi Y, Ju M, Gu W, Pei X, Yang R, Zhang L*. A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia. New England Journal of Medicine. 2024 Jun 20;390(23):2178-2190. (IF=96.2)

5. Chen Y#, Xu Y#, Chi Y#, Sun T#, Gao Y#, Dou X, Han Z, Xue F, Li H, Liu W, Liu X, Dong H, Fu R, Ju M, Dai X, Wang W, Ma Y, Song Z, Gu J, Gong W, Yang R, Zhang L*. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial. Signal Transduction and Targeted Therapy. 2024 Apr 23;9(1):102. (IF=40.8)

6. Zhang L#*. Gene therapy in China: past, present, and future. Lancet Haematology. 2022 Dec;9(12):e869-e871. (IF=24.7)

7. Xue F#, Wang P#, Yuan Z#, Shi C, Fang Y, Liu W, Wang Y, Xiao X, Yang R, George LA, Zhang L*. Total Knee Arthroplasty after Gene Therapy for Hemophilia B. New England Journal of Medicine. 2022 Oct 27;387(17):1622-1624. (IF=158.5)

8. Xue F#, Li H#, Wu X#, Liu W#, Zhang F, Tang D, Chen Y, Wang W, Chi Y, Zheng J, Du Z, Jiang W, Zhong C, Wei J, Zhu P, Fu R, Liu X, Chen L, Pei X, Sun J, Cheng T, Yang R*, Xiao X*, Zhang L*. Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial. Lancet Haematology. 2022 Jul;9(7):e504-e513. (IF=24.7)

9. Tong J#, Sun T#, Ma S#, Zhao Y#, Ju M#, Gao Y, Zhu P, Tan P, Fu R, Zhang A, Wang D, Wang D, Xiao Z, Zhou J, Yang R, Loughran SJ, Li J, Green AR, Bresnick EH, Wang D, Cheng T*, Zhang L*, Shi L*. Hematopoietic Stem Cell Heterogeneity Is Linked to the Initiation and Therapeutic Response of Myeloproliferative Neoplasms. Cell Stem Cell. 2021 Mar 4;28(3):502-513.e6. (IF=25.269)

10. Jiang H, Yu Z, Ding N, Yang M, Zhang L, Fan X, Zhou Y, Zou Q, Hou J, Zheng J, Zhang L*, Xu Y*, Liu J*. The role of AGK in thrombocytopoiesis and possible therapeutic strategies. Blood. 2020 Jul 2;136(1):119-129. (IF=22.113)